ields: Endocrinology and Metabolism: Hormones and their effects on body growth and metabolism. Genetics: Chromosomes, genes and their expression. Hematology: Blood and bone marrow cells. Coagulation: Process of blood clotting. Neurology: Nervous system, its structure and its diseases. Immunology: Immune system, including antibodies, cytokines, immune system cells and their effect, receptor systems and autoimmune diseases. Microbiology and Infectious Diseases: Microscopic forms of life, including parasites, bacteria, viruses, fungi and other infectious agents. Oncology: Abnormal cell growth, including pre-cancerous conditions and cancer. Serology: Body fluids and their analysis, including antibodies, proteins and other characteristics. Toxicology: Chemicals and drugs and their intended and adverse effects on the body. The company provides its services through its nationwide network of major laboratories, anatomic pathology laboratories and rapid response laboratories. The company conducts esoteric testing, including molecular diagnostics, in its Quest Diagnostics Nichols Institute laboratory facilities and in other facilities, including Focus Diagnostics and Athena Diagnostics. The company also provides routine testing services, and inpatient anatomic pathology and medical director services, at hospital laboratories. The company’s services primarily are provided under the Quest Diagnostics brand, and it also provides services under the AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Solstas, and Summit Health brands. International The company provides diagnostic information services in multiple markets outside the United States. The company has laboratory facilities in Gurgaon, India; Mexico City, Mexico; and San Juan, Puerto Rico. Diagnostic Solutions business This business offers various solutions for insurers and healthcare providers. The company provides risk assessment services for the life insurance industry. In addition, it offers healthcare organizations and clinicians health information technology solutions and diagnostic products. Risk Assessment Services ExamOne is the major provider of risk assessment services to the life insurance industry in North America. The company also provides risk assessment services for insurance companies operating outside North America. The company’s risk assessment services comprise underwriting support services, including data gathering, paramedical examinations and clinical laboratory testing and analytics, designed to assist life insurance companies objectively to evaluate the mortality risks of applicants. Most specimen collections and paramedical examinations are performed by the company’s network of paramedical examiners at the applicant's home or workplace, and they are also offered at approximately 600 company patient service centers in the United States and approximately 120 additional locations in North America. The company also contracts with third parties to coordinate providing these exams at approximately 350 additional locations outside North America. In 2015, ExamOne improved its service offering when it acquired the assets of Superior Mobile Medics, a national provider of paramedical and health data collection services to the life insurance, employer health and wellness industries. Diagnostic Products The company’s diagnostic products business develops, manufactures and markets diagnostic products, which could be used on various instrument platforms that enable healthcare professionals to make healthcare diagnoses. The company offers these products to a spectrum of customers in the United States, and through distributors, in other countries. Healthcare Information Technology The company’s Care360 EHR product allows clinicians to generate a complete record of a clinical patient encounter, automates and streamlines the clinician's workflow, and allows for deployment and implementation with minimal workflow disruption. The solution allows doctors to electronically create, manage and distribute patient encounter notes and allows for patient communication through a pa
quest diagnostics inc (DGX:New York)
3 Giralda Farms
Madison, NJ 07940
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for DGX.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact QUEST DIAGNOSTICS INC, please visit www.questdiagnostics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.